Advantages of modern methods of prevention of thrombotic complications in patients with critical ischemia of lower limbs after reconstructive operations
- Authors: Katelnitskiy I.I.1, Katelnitskiy I.I.1, Livadnyaya E.S.1
-
Affiliations:
- Rostov State Medical University
- Issue: Vol 27, No 4 (2019)
- Pages: 487-494
- Section: Original study
- URL: https://journals.rcsi.science/pavlovj/article/view/11798
- DOI: https://doi.org/10.23888/PAVLOVJ2019274487-494
- ID: 11798
Cite item
Abstract
Aim. To evaluate and improve the results of reconstructive operations in patients with obliterating atherosclerosis with critical ischemia of the lower limbs through reduction of the rate of thrombotic complications by improvement of diagnosis of risk factors for thrombosis on the basis of coagulogram and Thrombodynamics T-2 test data.
Materials and Methods. In the I group of patients (n=48) reconstructive operations were performed on the arteries of lower limbs and anticoagulant therapy with unfractionated heparin (UFH) with control of hemostasiogram before the operation, in 6 hours and 6 days after the operation and with additional control of APTT 30 minutes before introduction of UNH. In the II group (n=34) reconstructive operations were performed with selection of anticoagulant therapy using parameters of hemostasiogram and laboratory-diagnostic system Thrombodynamics Recorder T-2 with control before the operation, in 6 hours, 6 days after the operation and with additional control of APTT in 30 minutes before introduction of UFH.
Results. Analysis of the data of coagulogram and Thrombodynamics T-2 test showed statistical significance of APTT, fibrinogen, delay and initial speed of clot growth, a combination of which permits a possibility for correction of heparin therapy for prevention of thrombosis.
Conclusions. The dynamics of the parameters of Thrombodynamics T-2 test in selection of UFH dose proves high effectiveness of this method for selection of adequate doses of anticoagulant drugs for prevention of postoperative thromboses in patients with critical ischemia of the lower limbs.
Full Text
##article.viewOnOriginalSite##About the authors
Ivan I. Katelnitskiy
Rostov State Medical University
Email: katelnizkji@mail.ru
ORCID iD: 0000-0001-9913-740X
SPIN-code: 1301-6207
ResearcherId: P-5936-2016
MD, PhD, Professor, Head of the Department of Surgical Diseases №1
Russian Federation, Rostov-on-DonIgor I. Katelnitskiy
Rostov State Medical University
Email: katelnizkji@mail.ru
ORCID iD: 0000-0002-3745-9064
SPIN-code: 3583-6234
ResearcherId: P-4046-2016
MD, PhD, Associate Professor, Professor of the Department of Surgical Diseases №1
Ekaterina S. Livadnyaya
Rostov State Medical University
Author for correspondence.
Email: livadnyaya@mail.ru
ORCID iD: 0000-0002-1148-1044
SPIN-code: 2252-5492
ResearcherId: G-9409-2019
MD, PhD, Assistant of the Department of Surgical Diseases №1
Russian Federation, Rostov-on-DonReferences
- Casu B, Naggi A, Torri G. Re-visiting the structure of heparin. Carbohydrate Research. 2015;403:60-8. doi: 10.1016/j.carres.2014.06.023
- Pityk OI, Prasol VA, Boĭko VV. The choice of the revascularization method in the patients with critical ischemia of the lower extremities. Klinichna Khirurhiia. 2013;(4):48-51.
- Abramov IS, Maitesyan DA, Lazaryan TA, et al. Remote results of semiclosed endarterectomy with a loop from the superficial femoral artery and femoropopliteal bypass grafting. Angiology and Vascular Surgery. 2014;20(4):147-51. (In Russ).
- Bajwa A, Wesolowski R, Patel A, et al. Assessment of Tissue Perfusion in the Lower Limb: Current Methods and Techniques Under Development. Circulation: Cardiovascular Imaging. 2014;7(5):836-43. doi: 10.1161/circimaging.114.002123
- Kovalenko VI, Temrezov MB, Klimovich LG, et al. Risk factors for thrombotic events in patients with critical lower extremity ischemia. Russian Medical Journal. 2012;(1):34-7. (In Russ).
- Clagett GP, Sobel M, Jackson MR, et al. Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 Suppl): 609S-26S. doi: 10.1378/chest. 126.3_suppl.609S
- Neufang A, Dorweiler B, Espinola-Klein C, et al. Outcomes of complex femorodistal sequential autologous vein and biologic prosthesis composite bypass grafts. Journal of Vascular Surgery. 2014; 60(6):1543-53. doi: 10.1016/j.jvs.2014.07.103
- Socea B, Constantin V, Carap A, et al. Lower limb revascularization – a continuous challenge. Chirurgia (Bucharest, Romania: 1990). 2011; 106(5):627-30.
- Bedenis R, Lethaby A, Maxwell H, et al. Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery. Cochrane Database of Systematic Reviews. 2015;(2):CD000535. doi:10.1002/ 14651858.CD000535.pub3